Private Placement

New preclinical data suggests Arcellx's CAR T therapy may offer a safer profile than rivals, potentially avoiding severe neurological side effects.

As GLP-1 drugs dominate, Veru Inc. advances a novel therapy to combat muscle loss, aiming for a new standard of 'quality' weight loss in older adults.

With a 90% clinical trial failure rate, BullFrog AI is launching a new tool to help drugmakers make smarter, risk-balanced R&D decisions.

With promising new pipeline data and a major earnings report looming, Aclaris Therapeutics heads to two investor summits, placing its strategy on display.

Fueled by strong investor demand, Meridian Mining has upsized its financing to C$50 million, accelerating its high-potential Cabaçal project in Brazil.

Vertical Aerospace and Marubeni target 2026 demo flights in Osaka, accelerating Japan's race to launch commercial electric air taxi services.

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

IDrive CEO Raghu Kulkarni proposes a new model of reality, deriving quantum mechanics from a 'pixelated' vacuum. Can it solve physics' biggest mysteries?

With $60M in public funds and a $120M investment, Xplore aims to connect over 70,000 underserved homes to 500 Mbps speeds, reshaping rural life.

With $10M in revenue and major institutional backing, Safe Project is proving that crypto infrastructure can be a sustainable business without token subsidies.

A former Navy SEAL's tech startup marks one year of using AI to help veterans navigate the VA claims maze for free, taking on predatory firms and red tape.

As AI moves from hype to enterprise reality, data integrity becomes critical. Ataccama's record Q4 growth reveals a new market imperative: data trust.

John Gaeta's Escape.ai partners with Play.Works to bring AI-driven short films to Roku and Fire TV, targeting a new generation of viewers.

Following a new White House mandate, Voyager Technologies is building the core infrastructure for a permanent lunar base, blending commerce and national security.

Estrella Immunopharma unveils promising Phase 1 data for its next-gen T-cell therapy, but can it overcome a crowded market and its own financial hurdles?

Cyber threat intelligence firm Intel 471 elevates CINO Michael DeBolt to President, signaling a strategy to embed deep operational expertise into its core.

Current blood thinners carry a risky trade-off. A new class of drugs targeting Factor XIa could prevent deadly clots without the dangerous bleeding.

Novo Nordisk exec Karin Conde-Knape joins Valo as CSO, signaling a major validation for AI's role in creating next-generation medicines.

The Trump Administration has unveiled a $12 billion strategic mineral stockpile to break reliance on China and secure the future of American manufacturing.

A new binational challenge offers $70,000 in funding, calling on students and entrepreneurs to build the next wave of water technology solutions.